Matches in Wikidata for { <http://www.wikidata.org/entity/Q59204715> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q59204715 description "article scientifique publié en 2009" @default.
- Q59204715 description "im April 2009 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59204715 description "wetenschappelijk artikel" @default.
- Q59204715 description "наукова стаття, опублікована у квітні 2009" @default.
- Q59204715 name "Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood−Brain Barrier" @default.
- Q59204715 name "Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood−Brain Barrier" @default.
- Q59204715 type Item @default.
- Q59204715 label "Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood−Brain Barrier" @default.
- Q59204715 label "Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood−Brain Barrier" @default.
- Q59204715 prefLabel "Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood−Brain Barrier" @default.
- Q59204715 prefLabel "Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood−Brain Barrier" @default.
- Q59204715 P1433 Q59204715-2D75A346-EC2F-4A19-8339-1102A1876D4F @default.
- Q59204715 P1476 Q59204715-41E7898C-0F44-4446-A71B-3E74772A38A4 @default.
- Q59204715 P2093 Q59204715-070B9279-8649-4BA1-9039-DF055EF2C8EC @default.
- Q59204715 P2093 Q59204715-1BC5DA4D-4C49-4F1C-8A27-D368C3BAADA7 @default.
- Q59204715 P2093 Q59204715-9E2446B9-0B06-404F-8A41-4824494AE7AC @default.
- Q59204715 P2093 Q59204715-E99D49CA-7517-4449-A1FE-9277C3E0F89B @default.
- Q59204715 P304 Q59204715-CBB986D5-4360-4DAF-A3A3-AB2D11C3B7B7 @default.
- Q59204715 P31 Q59204715-DF530DED-5928-4331-8E3E-4DCC4436D446 @default.
- Q59204715 P356 Q59204715-6D00B3E3-F843-4D88-81B3-19E96BB5FEC2 @default.
- Q59204715 P433 Q59204715-A2FF8B60-F6CA-4538-9F8B-8D01C996EF06 @default.
- Q59204715 P478 Q59204715-B8078475-3383-4704-97D4-D2DBA4A5B7F3 @default.
- Q59204715 P577 Q59204715-7EB7F96D-1483-45C1-8559-341F28C3FCF5 @default.
- Q59204715 P921 Q59204715-030E9B0D-6C6B-4651-A707-704BD44971E5 @default.
- Q59204715 P921 Q59204715-A954EFEE-5D0D-4AF4-9025-AFDC40B62EB3 @default.
- Q59204715 P921 Q59204715-F8F675FB-019B-485A-B8D2-4F34E5440AC2 @default.
- Q59204715 P356 BM900279C @default.
- Q59204715 P1433 Q1768006 @default.
- Q59204715 P1476 "Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood−Brain Barrier" @default.
- Q59204715 P2093 "Eun Seok Gil" @default.
- Q59204715 P2093 "Huining Xiao" @default.
- Q59204715 P2093 "Jianshu Li" @default.
- Q59204715 P2093 "Tao Lu Lowe" @default.
- Q59204715 P304 "1020-1020" @default.
- Q59204715 P31 Q13442814 @default.
- Q59204715 P356 "10.1021/BM900279C" @default.
- Q59204715 P433 "4" @default.
- Q59204715 P478 "10" @default.
- Q59204715 P577 "2009-04-13T00:00:00Z" @default.
- Q59204715 P921 Q18936 @default.
- Q59204715 P921 Q221694 @default.
- Q59204715 P921 Q61231 @default.